Novartis

Ebit Endring Dato
AbbVie USD 2.42B 2.1B 2024-03
Alcon AG USD 380M 100M 2024-03
Almirall EUR -15500000 11.84M 2024-03
Amgen USD 756M 1.04B 2024-03
AstraZeneca USD 3.21B 1.75B 2024-03
Bayer EUR 3.24B 1.3B 2024-03
Biogen USD 534M 22M 2024-03
Bristol-Myers Squibb USD -11091000000 13.7B 2024-03
Eli Lilly USD 2.72B 362.4M 2024-03
Fresenius EUR 529M 105M 2024-03
Fresenius Medical Care EUR 261.68M 214.32M 2024-03
Galapagos EUR 23.19M 70.2M 2024-03
Genmab DKK 1.72B 53M 2024-03
Gilead Sciences USD -4232000000 6.38B 2024-03
GlaxoSmithKline GBP 1.52B 48M 2024-03
GRIFOLS EUR 226.09M 16.98M 2023-12
Hikma Pharmaceutical USD 362M 109M 2023-06
J&J USD 3.87B 1.44B 2024-03
Lonza CHF 621M 280M 2023-06
Merck EUR 973M 70M 2024-03
Merck USD 5.97B 6.27B 2024-03
Novartis USD 3.35B 294M 2024-03
Novartis USD 3.35B 294M 2024-03
Orion EUR 56M 36.9M 2024-03
Pfizer USD 4.21B 4.34B 2024-03
Philips EUR -800000000 1.38B 2024-03
Recordati EUR 181.87M 28.43M 2024-03
Regeneron Pharmaceuticals USD 716.8M 286.1M 2024-03
Roche Holding CHF 10.6B 2.12B 2023-06
Sanofi EUR 1.6B 1.86B 2024-03
UCB EUR 341M 217M 2023-06



Novartis - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.